{"commentary":{"count":21,"free_build_floor":8,"listing_floor":3,"by_channel":{"youtube":8,"podcast":8,"x_thread":5},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT00262769\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"ABC-02","nct_id":"NCT00262769","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=abc-02-nct00262769. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"ABC-02","arms":[{"description":"Gemcitabine alone","label":"A - Gemcitabine","type":"EXPERIMENTAL"},{"description":"Gemcitabine and Cisplatin","label":"B - Gemcitabine and Cisplatin","type":"EXPERIMENTAL"}],"collaborators":["Eli Lilly and Company"],"completion_date":null,"conditions":["Extrahepatic Bile Duct Cancer","Gallbladder Cancer"],"enrollment":{"count":324,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"cisplatin","type":"DRUG"},{"name":"gemcitabine hydrochloride","type":"DRUG"}],"last_update":"2012-07-17","lead_sponsor":"University College, London","official_title":"Gemcitabine, Alone or in Combination With Cisplatin, in Patients With Advanced or Metastatic Cholangiocarcinomas and Other Biliary Tract Tumors: A Multicentre, Randomized Phase III Study","overall_status":"COMPLETED","phases":["PHASE3"],"primary_completion_date":{"date":"2008-08","type":"ACTUAL"},"primary_outcomes":[{"measure":"Overall Survival","timeFrame":"From date of randomisation till date of death or last date of follow-up (up to 5 years)"}],"references":[{"citation":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.","pmid":"20375404","type":"RESULT"},{"citation":"Lamarca A, Ross P, Wasan HS, Hubner RA, McNamara MG, Lopes A, Palmer DH, Valle JW, Bridgewater J. Advanced extrahepatic cholangiocarcinoma and gallbladder cancer: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials. JHEP Rep. 2026 Jul;8(7):101833. doi: 10.1016/j.jhepr.2026.101833. Epub 2026 Mar 24.","pmid":"41887529","type":"DERIVED"}],"start_date":{"date":"2005-05"},"study_type":"INTERVENTIONAL","title":"Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors","url":"https://clinicaltrials.gov/study/NCT00262769"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/abc-02-nct00262769"}